Therapeutic Agent for Malignant Mesothelioma and Immunostimulant
    6.
    发明申请
    Therapeutic Agent for Malignant Mesothelioma and Immunostimulant 有权
    恶性间皮瘤和免疫刺激剂的治疗剂

    公开(公告)号:US20110189237A1

    公开(公告)日:2011-08-04

    申请号:US13056443

    申请日:2009-07-30

    摘要: According to the present invention, a method for treating malignant mesothelioma using REIC/Dkk-3 and a therapeutic agent for malignant mesothelioma comprising REIC/Dkk-3 are provided. A mesothelioma therapeutic agent is provided, comprising the following REIC/Dkk-3 DNA or a vector comprising the DNA as an active ingredient: (a) a DNA consisting of the nucleotide sequence shown in SEQ ID NO: 1; or (b) a DNA hybridizing under stringent conditions to a DNA consisting of a nucleotide sequence complementary to the nucleotide sequence shown in SEQ ID NO: 1 and encoding a protein having apoptosis-inducing activity and IL-7 production-accelerating activity in cells.

    摘要翻译: 根据本发明,提供了使用REIC / Dkk-3治疗恶性间皮瘤的方法和包含REIC / Dkk-3的恶性间皮瘤治疗剂。 提供间皮瘤治疗剂,其包含以下REIC / Dkk-3 DNA或包含该DNA作为活性成分的载体:(a)由SEQ ID NO:1所示核苷酸序列组成的DNA; 或(b)在严格条件下与由与SEQ ID NO:1所示核苷酸序列互补的核苷酸序列组成的DNA杂交并编码细胞中具有凋亡诱导活性和IL-7生产加速活性的蛋白质的DNA。